Nuevo Usuario

Recordar Contraseña

Nutrición Hospitalaria 05519 / http://dx.doi.org/10.20960/nh.05519

Resumen| PDF (ENGLISH)

Trabajo Original

Predictive value of the Chinese Visceral Adiposity Index for disease activity and vedolizumab response in ulcerative colitis

Yibing Hu, Jiaojiao Wei, Minlihu Hu, Yuan Chen, Yafang Li, Chong Lu, Xiao-Yun Yang, Jin Ding, Qunying Wang

Prepublicado: 2025-09-05

Logo Descargas Número de descargas: 3 Logo Visitas Número de visitas: 8 Citas Citas: 0

Compártelo:

Objective: ulcerative colitis (UC) is characterized by chronic nonspecific inflammation of the intestinal tract. The identification of non-invasive biomarkers that can reflect intestinal inflammation and predict therapeutic response is vital. This study aimed to assess the predictive value of the Chinese Visceral Adiposity Index (CVAI) for the assessment of both disease activity and response to vedolizumab therapy. Method: this retrospective study analyzed clinical data from patients with UC between January 2021 and December 2023. Healthy individuals were recruited as controls. Disease activity was evaluated using the modified Mayo score, while clinical response was assessed using patient-reported outcomes (PRO2). Mayo Endoscopic Score (MES) was used for the grading of mucosal lesions. Receiver operating characteristic (ROC) curves were used to assess the ability of various indices to differentiate between patients with UC and healthy controls. Results: patients with UC (n = 82) had significantly higher CVAIs compared to healthy controls (n = 72) (36.34 ± 19.82 vs. 55.93 ± 25.14, p < 0.001). ROC analysis indicated that CVAI was the most effective predictive factor in distinguishing between patients with UC and healthy controls, with the highest area under the curve (AUC = 0.720). The CVAI was significantly correlated with clinical activity and endoscopic scores in patients with UC, while patients who responded to vedolizumab had lower pre-treatment CVAIs compared to non-responders (54.14 ± 15.45 vs. 72.84 ± 21.44, p = 0.002). A low pre-treatment CVAI score was also effective in predicting the response to vedolizumab (AUC = 0.789). Conclusion: The CVAI may be a valuable marker for assessing disease activity in UC and has the potential to predict the response to vedolizumab therapy.

Palabras Clave: Chinese Visceral Adiposity Index. Ulcerative colitis. Vedolizumab.

Descargar PDF (ENGLISH)

Bibliografía
Artículos Relacionados

Le Berre C, Honap S, Peyrin-Biroulet L. Ulcerative colitis. Lancet 2023;402:571-84.
DOI: 10.1016/S0140-6736(23)00966-2

Ng SC, Shi HY, Hamidi N, Underwood FE, Tang W, Benchimol EI, et al. Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies. Lancet 2017;390:2769-78.
DOI: 10.1016/S0140-6736(17)32448-0

Ng SC, Tang W, Ching JY, Wong M, Chow CM, Hui AJ, et al. Incidence and phenotype of inflammatory bowel disease based on results from the Asia-pacific Crohn's and colitis epidemiology study. Gastroenterology 2013;145:158-65.e2.
DOI: 10.1053/j.gastro.2013.04.007

Gros B, Kaplan GG. Ulcerative Colitis in Adults: A Review. JAMA 2023;330:951-65.
DOI: 10.1001/jama.2023.15389

Feagan BG, Rutgeerts P, Sands BE, Hanauer S, Colombel JF, Sandborn WJ, et al. Vedolizumab as induction and maintenance therapy for ulcerative colitis. N Engl J Med 2013;369:699-710.
DOI: 10.1056/NEJMoa1215734

Gros B, Ross H, Nwabueze M, Constantine-Cooke N, Derikx L, Lyons M, et al. Long-term outcomes and predictors of vedolizumab persistence in ulcerative colitis. Therap Adv Gastroenterol 2024;17:17562848241258372.
DOI: 10.1177/17562848241258372

Karaskova E, Velganova-Veghova M, Geryk M, Foltenova H, Kucerova V, Karasek D. Role of Adipose Tissue in Inflammatory Bowel Disease. Int J Mol Sci 2021;22:4226.
DOI: 10.3390/ijms22084226

Eder P, Adler M, Dobrowolska A, Kamhieh-Milz J, Witowski J. The Role of Adipose Tissue in the Pathogenesis and Therapeutic Outcomes of Inflammatory Bowel Disease. Cells 2019;8:628.
DOI: 10.3390/cells8060628

Graffy PM, Pickhardt PJ. Quantification of hepatic and visceral fat by CT and MR imaging: relevance to the obesity epidemic, metabolic syndrome and NAFLD. Br J Radiol 2016;89:20151024.
DOI: 10.1259/bjr.20151024

Amato MC, Giordano C, Galia M, Criscimanna A, Vitabile S, Midiri M, et al. Visceral Adiposity Index: a reliable indicator of visceral fat function associated with cardiometabolic risk. Diabetes Care 2010;33:920-2.
DOI: 10.2337/dc09-1825

Thomas DM, Bredlau C, Bosy-Westphal A, Mueller M, Shen W, Gallagher D, et al. Relationships between body roundness with body fat and visceral adipose tissue emerging from a new geometrical model. Obesity (Silver Spring) 2013;21:2264-71.
DOI: 10.1002/oby.20408

Krakauer NY, Krakauer JC. A new body shape index predicts mortality hazard independently of body mass index. PLoS One 2012;7:e39504.
DOI: 10.1371/journal.pone.0039504

Kahn HS. The "lipid accumulation product" performs better than the body mass index for recognizing cardiovascular risk: a population-based comparison. BMC Cardiovasc Disord 2005;5:26.
DOI: 10.1186/1471-2261-5-26

Xia MF, Chen Y, Lin HD, Ma H, Li XM, Aleteng Q, et al. A indicator of visceral adipose dysfunction to evaluate metabolic health in adult Chinese. Sci Rep 2016;6:38214.
DOI: 10.1038/srep38214

Tang M, Wei XH, Cao H, Zhen Q, Liu F, Wang YF, et al. Association between Chinese visceral adiposity index and metabolic-associated fatty liver disease in Chinese adults with type 2 diabetes mellitus. Front Endocrinol (Lausanne) 2022;13:935980.
DOI: 10.3389/fendo.2022.935980

Pan L, Xu Q, Liu J, Gao Y, Li J, Peng H, et al. Dose-response relationship between Chinese visceral adiposity index and type 2 diabetes mellitus among middle-aged and elderly Chinese. Front Endocrinol (Lausanne) 2022;13:959860.
DOI: 10.3389/fendo.2022.959860

Tang N, Chen H, Chen R, Tang W, Zhang H. Combination of serological biomarkers and clinical features to predict mucosal healing in Crohn's disease: a multicenter cohort study. BMC Gastroenterol 2022;22:229.
DOI: 10.1186/s12876-022-02304-y

Langley BO, Guedry SE, Goldenberg JZ, Hanes DA, Beardsley JA, Ryan JJ. Inflammatory Bowel Disease and Neutrophil-Lymphocyte Ratio: A Systematic Scoping Review. J Clin Med 2021;10:4219.
DOI: 10.3390/jcm10184219

Lee JW, Woo D, Kim KO, Kim ES, Kim SK, Lee HS, et al. Deep learning model using stool pictures for predicting endoscopic mucosal inflammation in patients with ulcerative colitis. Am J Gastroenterol 2025;120(1):213-24.
DOI: 10.14309/ajg.0000000000002978

Swanson G, Behara R, Braun R, Keshavarzian A. Diagnostic medical radiation in inflammatory bowel disease: how to limit risk and maximize benefit. Inflamm Bowel Dis 2013;19:2501-8.
DOI: 10.1097/MIB.0b013e31828dc6b6

Ślósarz D, Poniewierka E, Neubauer K, Kempiński R. Ultrasound Elastography in the Assessment of the Intestinal Changes in Inflammatory Bowel Disease-Systematic Review. J Clin Med 2021;10:4044.
DOI: 10.3390/jcm10184044

Minordi LM, Bevere A, Papa A, Larosa L, Manfredi R. CT and MRI Evaluations in Crohn's Complications: A Guide for the Radiologist. Acad Radiol 2022;29:1206-27.
DOI: 10.1016/j.acra.2021.07.025

Bojarski C, Waldner M, Rath T, Schürmann S, Neurath MF, Atreya R, et al. Innovative Diagnostic Endoscopy in Inflammatory Bowel Diseases: From High-Definition to Molecular Endoscopy. Front Med (Lausanne) 2021;8:655404.
DOI: 10.3389/fmed.2021.655404

Nardo GD, Esposito G, Ziparo C, Micheli F, Masoni L, Villa MP, et al. Enteroscopy in children and adults with inflammatory bowel disease. World J Gastroenterol 2020;26:5944-58.
DOI: 10.3748/wjg.v26.i39.5944

Mosli MH, Zou G, Garg SK, Feagan SG, MacDonald JK, Chande N, et al. C-Reactive Protein, Fecal Calprotectin, and Stool Lactoferrin for Detection of Endoscopic Activity in Symptomatic Inflammatory Bowel Disease Patients: A Systematic Review and Meta-Analysis. Am J Gastroenterol 2015;110:802-19; quiz 820.
DOI: 10.1038/ajg.2015.120

Bryant RV, Schultz CG, Ooi S, Goess C, Costello SP, Vincent AD, et al. Visceral Adipose Tissue Is Associated With Stricturing Crohn's Disease Behavior, Fecal Calprotectin, and Quality of Life. Inflamm Bowel Dis 2019;25:592-600.
DOI: 10.1093/ibd/izy278

Thiberge C, Charpentier C, Gillibert A, Modzelewski R, Dacher JN, Savoye G, et al. Lower Subcutaneous or Visceral Adiposity Assessed by Abdominal Computed Tomography Could Predict Adverse Outcome in Patients With Crohn's Disease. J Crohns Colitis 2018;12:1429-37.
DOI: 10.1093/ecco-jcc/jjy124

Yadav DP, Kedia S, Madhusudhan KS, Bopanna S, Goyal S, Jain S, et al. Body Composition in Crohn's Disease and Ulcerative Colitis: Correlation with Disease Severity and Duration. Can J Gastroenterol Hepatol 2017;2017:1215035.
DOI: 10.1155/2017/1215035

Sehgal P, Su S, Zech J, Nobel Y, Luk L, Economou I, et al. Visceral Adiposity Independently Predicts Time to Flare in Inflammatory Bowel Disease but Body Mass Index Does Not. Inflamm Bowel Dis 2024;30:594-601.
DOI: 10.1093/ibd/izad111

Li Y, Yu D, Yang Y, Cheng X, Piao W, Guo Q, et al. Comparison of Several Adiposity Indexes in Predicting Hypertension among Chinese Adults: Data from China Nutrition and Health Surveillance (2015-2017). Nutrients 2023;15:2146.
DOI: 10.3390/nu15092146

Je Y, Han K, Chun J, Kim Y, Kim JH, Hoon Youn Y, et al. Association of Waist Circumference with the Risk of Inflammatory Bowel Disease: a Nationwide Cohort Study of 10 Million Individuals in Korea. J Crohns Colitis 2023;17:681-92.
DOI: 10.1093/ecco-jcc/jjac193

Pasanta D, Htun KT, Pan J, Tungjai M, Kaewjaeng S, Chancharunee S, et al. Waist Circumference and BMI Are Strongly Correlated with MRI-Derived Fat Compartments in Young Adults. Life (Basel) 2021;11:643.
DOI: 10.3390/life11070643

Yarur AJ, Bruss A, Moosreiner A, Beniwal-Patel P, Nunez L, Berens B, et al. Higher Intra-Abdominal Visceral Adipose Tissue Mass Is Associated With Lower Rates of Clinical and Endoscopic Remission in Patients With Inflammatory Bowel Diseases Initiating Biologic Therapy: Results of the Constellation Study. Gastroenterology 2023;165:963-75.e5.
DOI: 10.1053/j.gastro.2023.06.036

Morshedzadeh N, Shahrokh S, Aghdaei HA, Amin Pourhoseingholi M, Chaleshi V, Hekmatdoost A, et al. Effects of flaxseed and flaxseed oil supplement on serum levels of inflammatory markers, metabolic parameters and severity of disease in patients with ulcerative colitis. Complement Ther Med 2019;46:36-43.
DOI: 10.1016/j.ctim.2019.07.012

Deurenberg P, Deurenberg-Yap M, Guricci S. Asians are different from Caucasians and from each other in their body mass index/body fat per cent relationship. Obes Rev 2002;3:141-6.
DOI: 10.1046/j.1467-789X.2002.00065.x

Nishida C, Ko GT, Kumanyika S. Body fat distribution and noncommunicable diseases in populations: overview of the 2008 WHO Expert Consultation on Waist Circumference and Waist-Hip Ratio. Eur J Clin Nutr 2010;64:2-5.
DOI: 10.1038/ejcn.2009.139

Koutroumpakis E, Ramos-Rivers C, Regueiro M, Hashash JG, Barrie A, Swoger J, et al. Association Between Long-Term Lipid Profiles and Disease Severity in a Large Cohort of Patients with Inflammatory Bowel Disease. Dig Dis Sci 2016;61:865-71.
DOI: 10.1007/s10620-015-3932-1

Huang K, Liu J, Xia W, Tian C, Yao L, Cao Q, et al. Effectiveness and safety of vedolizumab for ulcerative colitis: a single-center retrospective real-world study in China. Front Pharmacol 2023;14:1188751.
DOI: 10.3389/fphar.2023.1188751

Kim J, Yoon H, Kim N, Lee KM, Jung SA, Choi CH, et al. Clinical Outcomes and Response Predictors of Vedolizumab Induction Treatment for Korean Patients With Inflammatory Bowel Diseases Who Failed Anti-TNF Therapy: A KASID Prospective Multicenter Cohort Study. Inflamm Bowel Dis 2021;27:1931-41.
DOI: 10.1093/ibd/izaa361

Gu P, Chhabra A, Chittajallu P, Chang C, Mendez D, Gilman A, et al. Visceral Adipose Tissue Volumetrics Inform Odds of Treatment Response and Risk of Subsequent Surgery in IBD Patients Starting Antitumor Necrosis Factor Therapy. Inflamm Bowel Dis 2022;28:657-66.
DOI: 10.1093/ibd/izab167

Artículos más populares

Revisión: Inteligencia artificial generativa ChatGPT en nutrición clínica: avances y desafíos

ChatGPT y otras herramientas de inteligencia artif...

Publicado: 2024-12-31

Resumen | PDF

Trabajo Original: Nutrient imbalance and obesity in children with autism spectrum disorder

Introduction: children with ASD have a higher perc...

Publicado: 2024-07-14

Resumen | PDF

Revisión: Suplementación con micronutrientes y sus beneficios: ¿por qué y cuándo?

Introducción: los micronutrientes participan en la...

Publicado: 2025-07-18

Resumen | PDF

Licencia creative commons: Open Access bajo la licencia Creative Commons 4.0 CC BY-NC-SA
https://creativecommons.org/licenses/by-nc-sa/4.0/legalcode

Editado en Madrid por:

Diseño y Desarrollo web Im3diA comunicación

Trabajo Original

Predictive value of the Chinese Visceral Adiposity Index for disease activity and vedolizumab response in ulcerative colitis

Artículos Relacionados:

Artículo Especial: Nutrición en enfermedad inﬂamatoria intestinal

Artículo Especial: Guía ESPEN: Nutrición clínica en la enfermedad inflamatoria intestinal

Carta Editor: Beneficios de la gastrectomía vertical laparoscópica en pacientes obesos con colitis ulcerosa

Trabajo Original: Restriction of dairy products; a reality in infl ammatory bowel disease patients

Trabajo Original: Effect of zinc supplementation on superoxide dismutase activity in patients with ulcerative rectocolitis

Artículos más populares

Revisión: Inteligencia artificial generativa ChatGPT en nutrición clínica: avances y desafíos

Trabajo Original: Nutrient imbalance and obesity in children with autism spectrum disorder

Revisión: Suplementación con micronutrientes y sus beneficios: ¿por qué y cuándo?